NR4A1 and metastatic neoplasm: Multivariable analysis including age, visceral metastases, number of metastases, de novo metastatic disease, period of care, and hormone receptor status did not confirm this observation (adjusted HR, 0.92; 95% CI, 0.83-1.01; P = .07) (Figure 3).